Salud

Roche will halt a trial of a new immunotherapy for lung cancer after the drug failed to show benefits over Merck & Co’s established treatment

Sanofi and partner Regeneron on Wednesday won European Union approval for wider use of the injectable drug Dupixent in patients with chronic lung disease, a

British drugmaker GSK on Wednesday bought out partner CureVac from its alliance to develop influenza vaccines and COVID-19, boosting its RNA informatics expertise and expanding

The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s early-stage Alzheimer’s disease treatment, making it the second treatment to slow the progression of

The US government has granted $176 million to Moderna to advance the development of its avian flu vaccine. This comes as concerns mount over a

French drugmaker Sanofi is nearing a decision to invest 1.3 billion to 1.5 billion euros ($1.4 billion to $1.6 billion) to modernise its long-acting insulin

London’s High Court ruled on Tuesday that one of Moderna’s patents relating to technology key to the development of COVID-19 vaccines is invalid. Still, another

Scientists tracking the spread of bird flu are increasingly concerned that gaps in surveillance could keep them several steps behind a new pandemic. Many of

New regulations on vaping came into effect in Australia on Monday. E-cigarettes will be moved behind pharmacy counters in an attempt to curb vaping among

French drugmaker Sanofi is close to a decision to invest between 1.3 billion euros and 1.5 billion euros ($1.4 billion to $1.6 billion) in a